Carlos A. Larrauri, MSN

home / authors / carlos-a-larrauri-msn

Articles

schizophrenia

Early Intervention for Schizophrenia on the Horizon: Implications for Clinicians and Patients

Carlos A. Larrauri, MSN;Alessio Travaglia, PhD;Linda S. Brady, PhD
April 18th 2023

Schizophrenia is one of the most recognized yet least understood chronic brain disorders.

HIPAA vs Ethical Care: Accounting for Privacy With Neuropsychiatric Impairments

HIPAA vs Ethical Care: Accounting for Privacy With Neuropsychiatric Impairments

Carlos A. Larrauri, MSN;Harold J. Bursztajn, MD;Michael Ashley Stein, PhD, JD
November 8th 2022

The law presumes that individuals are rational. But what about when the patient has neuropsychiatric impairments that hinder judgement?

Adam Stern, MD, makes the case for a more human psychiatry in his new book.

Committed: Dispatches from a Psychiatrist in Training

Carlos A. Larrauri, MSN;Michael Ashley Stein, PhD, JD
February 13th 2022

Adam Stern, MD’s, book makes the case for a more human psychiatry.

Latest Updated Articles

sofiko14/Adobe Stock
Published: July 13th 2025 | Updated: July 18th 2025
Clinician Tips in Prescribing New Xanomeline-Trospium for Schizophrenia
Mini Quiz: Treatment for Pedophilia?
Published: March 19th 2021 | Updated: July 18th 2025
Mini Quiz: Treatment for Pedophilia?
Mini Quiz: Characterizing Sexual Deviation
Published: January 23rd 2017 | Updated: July 18th 2025
Mini Quiz: Characterizing Sexual Deviation
spyrakot/Adobe Stock
Published: July 14th 2025 | Updated: July 18th 2025
Eyes, Ears, and Emotion: Techniques to Tackle Diagnosing Bipolar Disorder
Dee/Adobe Stock
Published: July 12th 2025 | Updated: July 18th 2025
Toward a Muscarinic Agent Solution for the Presynaptic Dopamine Problem in Schizophrenia
Miquel/Adobe Stock
Published: July 13th 2025 | Updated: July 18th 2025
Robust Efficacy and Decreased Side Effects with New Muscarinic Agent for Treating Schizophrenia
© 2025 MJH Life Sciences

All rights reserved.